Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Prog Neurobiol. 2022 Jul 14;217:102316. doi: 10.1016/j.pneurobio.2022.102316

Table 1.

Effects of ELAVL4 expression manipulation on APP and tau phenotypes

APP Phenotypes Tau Phenotypes

RNA Protein Processing RNA Protein

Knock out
fADcorr
ELAVL4 KO
Total ↓ 97.9 % n.s. Total ↑100.1 % n.s. Aβ42/40 ↑ 104.1 % n.s. ↑ 111.9 % **** Total tau ↑ 124.8 % *
695 ↓ 97.2 % n.s. Aβ42 ↓ 90.0 % n.s. P-tau181 ↑ 105.2 % *
751 ↑ 127.6 % * Aβ40 ↓ 86.4 % *
770 ↑ 104.4 % n.s. Aβ38 ↓ 90.8 % n.s.
fAD
ELAVL4 KO
Total ↑112.0 % n.s. Total ↓ 79.7 % ** Aβ42/40 ↓ 97.7 % n.s. ↓ 93.2 % * Total tau ↑ 106.8 % n.s.
695 ↑100.2 % n.s. Aβ42 ↓ 84.3 % *** P-tau181 ↑ 104.4 % *
751 ↑ 121.9 % ** Aβ40 ↓ 86.6 % **
770 ↑ 213.5 % *** Aβ38 ↓ 82.2 % **
Over Expression
fADcorr
ELAVL4-sv2
Total ↑ 114.3 % * Total ↑ 114.7 % ** Aβ42/40 ↓ 90.1 % ** ↑ 103.9 % n.s. Total tau ↓ 94.0 % n.s.
695 ↑ 110.4 % ** Aβ42 ↓ 94.2 % n.s. P-tau181 ↓ 89.3 % *
751 ↓ 66.8 % **** Aβ40 ↑ 104.6 % n.s
770 ↓ 23.7 % **** Aβ38 ↑ 108.9 % n.s
fAD
ELAVL4-sv2
Total ↑ 118.9 % * Total ↑ 210.9 % **** Aβ42/40 ↓ 87.4 % **** ↑105.5 % n.s. DAKO ↓ 99.7 % n.s.
695 ↑ 126.8 % ** Aβ42 ↓ 85.4 % n.s P-tau181 ↓ 90.6 % *
751 ↓ 75.2 % *** Aβ40 ↓ 97.4 % n.s
770 ↓ 23.5 % **** Aβ38 ↓ 96.2 % n.s.
fADcorr
ELAVL4-sv1
Total ↑ 113.6 % * Total ↓ 85.1 % ** Aβ42/40 ↓ 88.1 % *** ↑ 110.0 % * Total tau ↑ 100.4 % n.s.
695 ↑ 112.5 % ** Aβ42 ↑ 110.7 % n.s P-Tau181 ↓ 83.7 % ***
751 ↓ 67.5 % **** Aβ40 ↑ 127.1 % **
770 ↓ 33.1 % **** Aβ38 ↑ 122.4 % **
fAD
ELAVL4-sv1
Total ↑102.1 % n.s. Total ↑ 145.9 % n.s. Aβ42/40 ↓ 83.9 % **** ↑ 114.0 % * Total tau ↑ 119.4 % **
695 ↑ 107.0 % Aβ42 ↓ 94.4 % n.s P-tau181 ↓ 83.3 % ****
751 ↓ 75.5 % ** Aβ40 ↑ 111.5 % n.s.
770 ↓ 33.6 % **** Aβ38 ↑ 103.6 % n.s.
Rescue in ELAVL4 KO
fADcorr
ELAVL4
KO ELAVL4-sv2
Total ↑ 105.7 % n.s. Total ↑ 140.8 % **** Aβ42/40 ↑ 100.8 % n.s ↓ 94.2 % n.s DAKO ↓ 86.7 % n.s.
695 ↑ 110.1 % n.s. Aβ42 ↓ 85.0 % n.s. P-tau181 ↓ 78.4 % ****
751 ↓ 54.7 % **** Aβ40 ↓ 84.6 % n.s.
770 ↓ 17.0 % *** Aβ38 ↓ 96.0 % n.s.
fAD
ELAVL4 KO

ELAVL4-sv2
Total ↑ 107.6 % n.s. Total ↑ 277.6 % ** Aβ42/40 ↓ 89.1 % *** ↑106.3 % n.s. DAKO ↓ 85.7 % n.s.
695 ↑ 103.9 % n.s. Aβ42 ↓ 92.4 % n.s P-tau181 ↓ 85.2 % ***
751 ↓ 53.5 % **** Aβ40 ↑ 103.6 % n.s.
770 ↓ 14.5 % **** Aβ38 ↑ 112.6 % n.s.
fADcorr
ELAVL4 KO
ELAVL4-sv1
Total ↑ 103.9 % n.s. Total ↑ 110.7 % n.s. Aβ42/40 ↓ 93.0 % * ↓ 95.4 % n.s DAKO ↓ 91.6 % n.s.
695 ↑ 107.7 % n.s. Aβ42 ↓ 95.4 % n.s. P-tau181 ↓ 70.4 % ****
751 ↓56.7 % **** Aβ40 ↑ 104.4 % n.s
770 ↓ 47.0 % ** Aβ38 ↓ 99.6 % n.s.
fAD
ELAVL4 KO

ELAVL4-sv1
Total ↑ 108.6 % n.s. Total ↑ 241.5 % * Aβ42/40 ↓ 88.4 % *** ↑ 111.3 % ** Total tau ↓ 89.1 % n.s.
695 ↑ 106.6 % n.s. Aβ42 ↓ 95.3 % n.s P-tau181 ↓ 81.8 % ****
751 ↓ 58.3 % **** Aβ40 ↑ 108.9 % n.s.
770 ↓ 19.7 % **** Aβ38 ↑ 113.3 % n.s.

NOTE. Summarized data. For all conditions: per condition, three replicates from three independent differentiations were used. Total protein determined by BCA was used to normalize measured values for individual Aβ species. For KO conditions: changes relative to CRISPR control line, P-value calculated with ↑ tests. For OE and rescue conditions: changes relative to empty vector control, P-values calculated with Dunnett’s multiple comparison that followed after ANOVA test.

*

P < 0.05

**

P < 0.01

***

P < 0.001

****

P < 0.0001